Lathouwers E - Search Results

1

Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients.

De Meyer S, Lathouwers E, Dierynck I, De Paepe E, Van Baelen B, Vangeneugden T, Spinosa-Guzman S, Lefebvre E, Picchio G, de Béthune MP. De Meyer S, et al. Among authors: lathouwers e. AIDS. 2009 Sep 10;23(14):1829-40. doi: 10.1097/QAD.0b013e32832cbcec. AIDS. 2009. PMID: 19474650 Clinical Trial.

2

In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients.

Dierynck I, De Meyer S, Lathouwers E, Vanden Abeele C, Van De Casteele T, Spinosa-Guzman S, de Béthune MP, Picchio G. Dierynck I, et al. Among authors: lathouwers e. Antivir Ther. 2010;15(8):1161-9. doi: 10.3851/IMP1697. Antivir Ther. 2010. PMID: 21149923 Clinical Trial.

3

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study: 96-week analysis.

Lathouwers E, De Meyer S, Dierynck I, Van de Casteele T, Lavreys L, de Béthune MP, Picchio G. Lathouwers E, et al. Antivir Ther. 2011;16(1):99-108. doi: 10.3851/IMP1719. Antivir Ther. 2011. PMID: 21311113 Clinical Trial.

4

Virological analysis of once-daily and twice-daily darunavir/ritonavir in the ODIN trial of treatment-experienced patients.

Lathouwers E, De La Rosa G, Van de Casteele T, Baeten B, Tomaka F, De Meyer S, Picchio G. Lathouwers E, et al. Antivir Ther. 2013;18(3):289-300. doi: 10.3851/IMP2569. Epub 2013 Apr 4. Antivir Ther. 2013. PMID: 23558157 Clinical Trial.

5

Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested United States clinical samples between 2006 and 2012.

Lathouwers E, Gupta S, Haddad M, Paquet A, de Meyer S, Baugh B. Lathouwers E, et al. AIDS Res Hum Retroviruses. 2015 Jun;31(6):628-35. doi: 10.1089/AID.2014.0020. Epub 2015 Mar 31. AIDS Res Hum Retroviruses. 2015. PMID: 25684627

6

HIV-1 resistance rarely observed in patients using darunavir once-daily regimens across clinical studies.

Lathouwers E, Wong EY, Luo D, Seyedkazemi S, De Meyer S, Brown K. Lathouwers E, et al. HIV Clin Trials. 2017 Nov-Dec;18(5-6):196-204. doi: 10.1080/15284336.2017.1387690. Epub 2017 Nov 16. HIV Clin Trials. 2017. PMID: 29143565

7

Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection.

Lathouwers E, Seyedkazemi S, Luo D, Brown K, De Meyer S, Wong EY. Lathouwers E, et al. HIV Res Clin Pract. 2020 Apr-Jun;21(2-3):83-89. doi: 10.1080/25787489.2020.1794439. Epub 2020 Jul 26. HIV Res Clin Pract. 2020. PMID: 32715952

8

Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial.

Orkin C, DeJesus E, Khanlou H, Stoehr A, Supparatpinyo K, Lathouwers E, Lefebvre E, Opsomer M, Van de Casteele T, Tomaka F. Orkin C, et al. Among authors: lathouwers e. HIV Med. 2013 Jan;14(1):49-59. doi: 10.1111/j.1468-1293.2012.01060.x. Epub 2012 Oct 23. HIV Med. 2013. PMID: 23088336 Free article. Clinical Trial.

9

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients.

Cahn P, Fourie J, Grinsztejn B, Hodder S, Molina JM, Ruxrungtham K, Workman C, Van De Casteele T, De Doncker P, Lathouwers E, Tomaka F. Cahn P, et al. Among authors: lathouwers e. AIDS. 2011 Apr 24;25(7):929-39. doi: 10.1097/QAD.0b013e328345ee95. AIDS. 2011. PMID: 21346512 Clinical Trial.

10

Week 96 resistance analyses of the once-daily, single-tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials.

Lathouwers E, Weinsteiger S, Baugh B, Ghys A, Jezorwski J, Mohsine EG, Van Landuyt E, De Meyer S. Lathouwers E, et al. J Med Virol. 2021 Jun;93(6):3985-3990. doi: 10.1002/jmv.26721. Epub 2021 Feb 15. J Med Virol. 2021. PMID: 33300183 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page